Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Acute Disease; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute Phase 3 ClinicalTrials
CONTENTS